Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. China
  4. Shanghai Stock Exchange
  5. Jiangsu Hengrui Medicine Co., Ltd.
  6. News
  7. Summary
    600276   CNE0000014W7

JIANGSU HENGRUI MEDICINE CO., LTD.

(600276)
  Report
SummaryChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsOther languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

Jiangsu Hengrui Pharmaceuticals Co., Ltd. Announces on Obtaining Notice of Approval of Clinical Trial for Medicine

05/21/2021 | 06:37am EDT

Jiangsu Hengrui Medicine Co., Ltd. announced on obtaining notice of approval of clinical trial for medicine.


ę S&P Capital IQ 2021
All news about JIANGSU HENGRUI MEDICINE CO., LTD.
08/26BeyondSpring Shares Up 17% After China Commercialization Deal
DJ
08/25Dalian Wanchun Brin Pharmaceutical Co., Ltd. announced that it expects to rec..
CI
08/19Jiangsu Hengrui Medicine Co., Ltd. Reports Earnings Results for the Half Year..
CI
07/01MARKET CHATTER : China Adds New Drugs to Cover Under Health Insurance Program
MT
06/24China stocks slip as healthcare firms retreat; Hong Kong up
RE
05/21Jiangsu Hengrui Pharmaceuticals Co., Ltd. Announces on Obtaining Notice of Ap..
CI
05/03Shanghai Fosun Pharmaceutical's H-Shares Surge to All-Time High
DJ
04/19Jiangsu Hengrui Medicine Co., Ltd. Reports Earnings Results for the First Qua..
CI
03/15EXCLUSIVE : China's JD.com in talks to buy stake worth $1.5 billion in brokerage..
RE
03/11Jiangsu Hengrui Medicine Co., Ltd. Announces Approval of Conducting Clinical ..
CI
More news
Financials
Sales 2021 32 579 M 5 039 M 5 039 M
Net income 2021 6 901 M 1 067 M 1 067 M
Net cash 2021 17 800 M 2 753 M 2 753 M
P/E ratio 2021 43,0x
Yield 2021 0,41%
Capitalization 299 B 46 271 M 46 275 M
EV / Sales 2021 8,64x
EV / Sales 2022 7,34x
Nbr of Employees 28 903
Free-Float 47,0%
Chart JIANGSU HENGRUI MEDICINE CO., LTD.
Duration : Period :
Jiangsu Hengrui Medicine Co., Ltd. Technical Analysis Chart | 600276 | CNE0000014W7 | MarketScreener
Technical analysis trends JIANGSU HENGRUI MEDICINE CO., LTD.
Short TermMid-TermLong Term
TrendsBearishBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 24
Last Close Price 46,95 CNY
Average target price 75,31 CNY
Spread / Average Target 60,4%
EPS Revisions
Managers and Directors
Song Zhou Chief Financial Officer
Wei Dong Chairman-Supervisory Board
Piao Yang Sun Chairman
Shuang Xue Independent Director
Qian Wang Independent Director
Sector and Competitors
1st jan.Capi. (M$)
JIANGSU HENGRUI MEDICINE CO., LTD.-49.45%46 271
JOHNSON & JOHNSON4.09%433 701
ROCHE HOLDING AG10.97%321 442
PFIZER, INC.19.23%246 078
NOVO NORDISK A/S50.80%232 556
ELI LILLY AND COMPANY37.20%208 604